Cytoplasmic motifs in the nipah virus fusion protein modulate virus particle assembly and egress

Journal of Virology

Volumn 91, Issue 10, 2017, Pages

  Johnston, Gunner P ^a   Contreras, Erik M ^a   Dabundo, Jeffrey ^a   Henderson, Bryce A ^a   Matz, Keesha M ^a   Ortega, Victoria ^a   Ramirez, Alfredo ^a   Park, Arnold ^b   Aguilar, Hector C ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Attachment; Budding; Cytoplasmic tail; Fusion protein; Glycoprotein; Matrix; Nipah virus; Paramyxoviridae; Paramyxovirus; Viral assembly

Indexed keywords

ADAPTOR PROTEIN; GLYCOPROTEIN; MATRIX PROTEIN; VIRUS FUSION PROTEIN; F PROTEIN, NIPAH VIRUS; VIRUS ENVELOPE PROTEIN; VIRUS LIKE PARTICLE VACCINE;

ARTICLE; CELL MEMBRANE; CLUSTER ANALYSIS; CONTROLLED STUDY; DENSITOMETRY; FLOW CYTOMETRY; GENE MUTATION; GENETIC TRANSFECTION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HUMAN CELL; NIPAH VIRUS INFECTION; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; VIRUS PARTICLE; VIRUS RELEASE; WESTERN BLOTTING; ANIMAL; CHEMISTRY; CYTOPLASM; GENETICS; METABOLISM; NIPAH VIRUS; PHYSIOLOGY; PROTEIN DOMAIN; PROTEIN MOTIF; VIRION; VIRUS ASSEMBLY; VIRUS ENTRY;

AMINO ACID MOTIFS; ANIMALS; CYTOPLASM; GLYCOPROTEINS; HUMANS; NIPAH VIRUS; PROTEIN DOMAINS; VACCINES, VIRUS-LIKE PARTICLE; VIRAL ENVELOPE PROTEINS; VIRAL FUSION PROTEINS; VIRAL MATRIX PROTEINS; VIRION; VIRUS ASSEMBLY; VIRUS INTERNALIZATION; VIRUS RELEASE;

EID: 85018321519     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02150-16     Document Type: Article

References (62)

1. Luby SP, Hossain MJ, Gurley ES, Ahmed B-N, Banu S, Khan SU, Homaira N, Rota PA, Rollin PE, Comer JA, Kenah E, Ksiazek TG, Rahman M. 2009. Recurrent zoonotic transmission of Nipah virus into humans, Bangladesh, 2001-2007. Emerg Infect Dis 15:1229-1235. https://doi.org/10 .3201/eid1508.081237.
2. Wu Z, Yang L, Yang F, Ren X, Jiang J, Dong J, Sun L, Zhu Y, Zhou H, Jin Q. 2014. Novel henipa-like virus, Mojiang paramyxovirus, in rats, China, 2012. Emerg Infect Dis 20:1064-1066. https://doi.org/10.3201/eid2006 .131022.
3. Drexler JF, Corman VM, Müller MA, Maganga GD, Vallo P, Binger T, Gloza-Rausch F, Rasche A, Yordanov S, Seebens A, Oppong S, Sarkodie YA, Pongombo C, Lukashev AN, Schmidt-Chanasit J, Stöcker A, Carneiro AJB, Erbar S, Maisner A, Fronhoffs F, Buettner R, Kalko EKV, Kruppa T, Franke CR, Kallies R, Yandoko ERN, Herrler G, Reusken C, Hassanin A, Krüger DH, Matthee S, Ulrich RG, Leroy EM, Drosten C. 2012. Bats host major mammalian paramyxoviruses. Nat Commun 3:796. https://doi.org/ 10.1038/ncomms1796.
4. Chua KB. 2000. Nipah virus: a recently emergent deadly paramyxovirus. Science 288:1432-1435. https://doi.org/10.1126/science.288 .5470.1432.
5. Enserink M. 1999. Epidemiology: new virus fingered in Malaysian epidemic. Science 284:407-410. https://doi.org/10.1126/science.284.5413 .407.
6. Parashar UD, Sunn LM, Ong F, Mounts AW, Arif MT, Ksiazek TG, Kamaluddin MA, Mustafa AN, Kaur H, Ding LM, Othman G, Radzi HM, Kitsutani PT, Stockton PC, Arokiasamy J, Gary HE Jr, Anderson LJ. 2000. Casecontrol study of risk factors for human infection with a new zoonotic paramyxovirus, Nipah virus, during a 1998-1999 outbreak of severe encephalitis in Malaysia. J Infect Dis 181:1755-1759. https://doi.org/10 .1086/315457.
7. Aguilar HC, Lee B. 2011. Emerging paramyxoviruses: molecular mechanisms and antiviral strategies. Expert Rev Mol Med 13:e6. https://doi.org/ 10.1017/S1462399410001754.
8. World Health Organization. 2015. Blueprint for R&D preparedness and response to public health emergencies due to highly infectious pathogens. World Health Organization, Geneva, Switzerland.
9. Samal SK (ed). 2011. The biology of paramyxoviruses. Caister Academic Press, Norfolk, United Kingdom.
10. Wong KT, Shieh W-J, Kumar S, Norain K, Abdullah W, Guarner J, Goldsmith CS, Chua KB, Lam SK, Tan CT, Goh KJ, Chong HT, Jusoh R, Rollin PE, Ksiazek TG, Zaki SR; Nipah Virus Pathology Working Group. 2002. Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis. Am J Pathol 161:2153-2167. https://doi.org/10.1016/ S0002-9440(10)64493-8.
11. Aguilar HC, Iorio RM. 2012. Henipavirus membrane fusion and viral entry, p 79-94. In Lee B, Rota PA (ed), Henipavirus. Springer, Berlin, Germany.
12. Harrison MS, Sakaguchi T, Schmitt AP. 2010. Paramyxovirus assembly and budding: building particles that transmit infections. Int J Biochem Cell Biol 42:1416-1429. https://doi.org/10.1016/j.biocel .2010.04.005.
13. Aguilar HC, Henderson BA, Zamora JL, Johnston GP. 2016. Paramyxovirus glycoproteins and the membrane fusion process. Curr Clin Microbiol Rep 3:142-154. https://doi.org/10.1007/s40588-016-0040-8.
14. Negrete OA, Wolf MC, Aguilar HC, Enterlein S, Wang W, Mühlberger E, Su SV, Bertolotti-Ciarlet A, Flick R, Lee B. 2006. Two key residues in EphrinB3 are critical for its use as an alternative receptor for Nipah virus. PLoS Pathog 2:e7. https://doi.org/10.1371/journal.ppat.0020007.
15. Negrete OA, Levroney EL, Aguilar HC, Bertolotti-Ciarlet A, Nazarian R, Tajyar S, Lee B. 2005. EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus. Nature 436:401-405.
16. Aguilar HC, Aspericueta V, Robinson LR, Aanensen KE, Lee B. 2010. A quantitative and kinetic fusion protein-triggering assay can discern distinct steps in the Nipah virus membrane fusion cascade. J Virol 84:8033-8041. https://doi.org/10.1128/JVI.00469-10.
17. Liu Q, Stone JA, Bradel-Tretheway B, Dabundo J, Benavides Montano JA, Santos-Montanez J, Biering SB, Nicola AV, Iorio RM, Lu X, Aguilar HC. 2013. Unraveling a three-step spatiotemporal mechanism of triggering of receptor-induced Nipah virus fusion and cell entry. PLoS Pathog 9:e1003770. https://doi.org/10.1371/journal.ppat.1003770.
18. Bonaparte MI, Dimitrov AS, Bossart KN, Crameri G, Mungall BA, Bishop KA, Choudhry V, Dimitrov DS, Wang L-F, Eaton BT, Broder CC. 2005. Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. Proc Natl Acad Sci U S A 102:10652-10657. https://doi.org/10 .1073/pnas.0504887102.
19. Lamp B, Dietzel E, Kolesnikova L, Sauerhering L, Erbar S, Weingartl H, Maisner A. 2013. Nipah virus entry and egress from polarized epithelial cells. J Virol 87:3143-3154. https://doi.org/10.1128/JVI.02696-12.
20. Erbar S, Maisner A. 2010. Nipah virus infection and glycoprotein targeting in endothelial cells. Virol J 7:305. https://doi.org/10.1186/1743-422X-7-305.
21. Mattera R, Farías GG, Mardones GA, Bonifacino JS. 2014. Co-assembly of viral envelope glycoproteins regulates their polarized sorting in neurons. PLoS Pathog 10:e1004107. https://doi.org/10.1371/journal .ppat.1004107.
22. Ciancanelli MJ, Basler CF. 2006. Mutation of YMYL in the Nipah virus matrix protein abrogates budding and alters subcellular localization. J Virol 80:12070-12078. https://doi.org/10.1128/JVI.01743-06.
23. Coronel EC, Murti KG, Takimoto T, Portner A. 1999. Human parainfluenza virus type 1 matrix and nucleoprotein genes transiently expressed in mammalian cells induce the release of virus-like particles containing nucleocapsid-like structures. J Virol 73:7035-7038.
24. Pantua HD, McGinnes LW, Peeples ME, Morrison TG. 2006. Requirements for the assembly and release of Newcastle disease virus-like particles. J Virol 80:11062-11073. https://doi.org/10.1128/JVI.00726-06.
25. Patch JR, Crameri G, Wang L-F, Eaton BT, Broder CC. 2007. Quantitative analysis of Nipah virus proteins released as virus-like particles reveals central role for the matrix protein. Virol J 4:1. https://doi.org/10.1186/ 1743-422X-4-1.
26. Pohl C, Duprex WP, Krohne G, Rima BK, Schneider-Schaulies S. 2007. Measles virus M and F proteins associate with detergent-resistant membrane fractions and promote formation of virus-like particles. J Gen Virol 88:1243-1250. https://doi.org/10.1099/vir.0.82578-0.
27. Runkler N, Pohl C, Schneider-Schaulies S, Klenk H-D, Maisner A. 2007. Measles virus nucleocapsid transport to the plasma membrane requires stable expression and surface accumulation of the viral matrix protein. Cell Microbiol 9:1203-1214. https://doi.org/10.1111/j.1462-5822.2006 .00860.x.
28. Sugahara F, Uchiyama T, Watanabe H, Shimazu Y, Kuwayama M, Fujii Y, Kiyotani K, Adachi A, Kohno N, Yoshida T, Sakaguchi T. 2004. Paramyxovirus Sendai virus-like particle formation by expression of multiple viral proteins and acceleration of its release by C protein. Virology 325:1-10. https://doi.org/10.1016/j.virol.2004.04.019.
29. Takimoto T, Murti KG, Bousse T, Scroggs RA, Portner A. 2001. Role of matrix and fusion proteins in budding of Sendai virus. J Virol 75: 11384-11391. https://doi.org/10.1128/JVI.75.23.11384-11391.2001.
30. Li M, Schmitt PT, Li Z, McCrory TS, He B, Schmitt AP. 2009. Mumps virus matrix, fusion, and nucleocapsid proteins cooperate for efficient production of virus-like particles. J Virol 83:7261-7272. https://doi.org/10.1128/ JVI.00421-09.
31. Schmitt AP, Leser GP, Waning DL, Lamb RA. 2002. Requirements for budding of paramyxovirus simian virus 5 virus-like particles. J Virol 76:3952-3964. https://doi.org/10.1128/JVI.76.8.3952-3964.2002.
32. Walpita P, Barr J, Sherman M, Basler CF, Wang L. 2011. Vaccine potential of Nipah virus-like particles. PLoS One 6:e18437. https://doi.org/10.1371/ journal.pone.0018437.
33. Landowski M, Dabundo J, Liu Q, Nicola AV, Aguilar HC. 2014. Nipah virion entry kinetics, composition, and conformational changes determined by enzymatic virus-like particles and new flow virometry tools. J Virol 88:14197-14206. https://doi.org/10.1128/JVI.01632-14.
34. Vogt C, Eickmann M, Diederich S, Moll M, Maisner A. 2005. Endocytosis of the Nipah virus glycoproteins. J Virol 79:3865-3872. https://doi.org/ 10.1128/JVI.79.6.3865-3872.2005.
35. Aguilar HC, Matreyek KA, Choi DY, Filone CM, Young S, Lee B. 2007. Polybasic KKR motif in the cytoplasmic tail of Nipah virus fusion protein modulates membrane fusion by inside-out signaling. J Virol 81: 4520-4532. https://doi.org/10.1128/JVI.02205-06.
36. Khetawat D, Broder CC. 2010. A functional henipavirus envelope glycoprotein pseudotyped lentivirus assay system. Virol J 7:312. https://doi .org/10.1186/1743-422X-7-312.
37. Weise C, Erbar S, Lamp B, Vogt C, Diederich S, Maisner A. 2010. Tyrosine residues in the cytoplasmic domains affect sorting and fusion activity of the Nipah virus glycoproteins in polarized epithelial cells. J Virol 84: 7634-7641. https://doi.org/10.1128/JVI.02576-09.
38. El Najjar F, Schmitt A, Dutch R. 2014. Paramyxovirus glycoprotein incorporation, assembly and budding: a three-way dance for infectious particle production. Viruses 6:3019-3054. https://doi.org/10 .3390/v6083019.
39. Yonemura S, Hirao M, Doi Y, Takahashi N, Kondo T, Tsukita S, Tsukita S. 1998. Ezrin/radixin/moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmic domain of CD44, CD43, and ICAM-2. J Cell Biol 140:885-895. https://doi.org/10.1083/jcb .140.4.885.
40. Deschambeault J, Lalonde JP, Cervantes-Acosta G, Lodge R, Cohen EA, Lemay G. 1999. Polarized human immunodeficiency virus budding in lymphocytes involves a tyrosine-based signal and favors cell-to-cell viral transmission. J Virol 73:5010-5017.
41. Lodge R. 1997. The membrane-proximal intracytoplasmic tyrosine residue of HIV-1 envelope glycoprotein is critical for basolateral targeting of viral budding in MDCK cells. EMBO J 16:695-705. https://doi.org/10 .1093/emboj/16.4.695.
42. Noble B, Abada P, Nunez-Iglesias J, Cannon PM. 2006. Recruitment of the adaptor protein 2 complex by the human immunodeficiency virus type 2 envelope protein is necessary for high levels of virus release. J Virol 80:2924-2932. https://doi.org/10.1128/JVI.80.6.2924-2932.2006.
43. Abada P, Noble B, Cannon PM. 2005. Functional domains within the human immunodeficiency virus type 2 envelope protein required to enhance virus production. J Virol 79:3627-3638. https://doi.org/10.1128/ JVI.79.6.3627-3638.2005.
44. Diederich S, Sauerhering L, Weis M, Altmeppen H, Schaschke N, Reinheckel T, Erbar S, Maisner A. 2012. Activation of the Nipah virus fusion protein in MDCK cells is mediated by cathepsin B within the endosomerecycling compartment. J Virol 86:3736-3745. https://doi.org/10.1128/ JVI.06628-11.
45. Votteler J, Sundquist WI. 2013. Virus budding and the ESCRT pathway. Cell Host Microbe 14:232-241. https://doi.org/10.1016/j.chom.2013.08 .012.
46. Rossman JS, Jing X, Leser GP, Lamb RA. 2010. Influenza virus M2 protein mediates ESCRT-independent membrane scission. Cell 142:902-913. https://doi.org/10.1016/j.cell.2010.08.029.
47. Chen BJ, Leser GP, Morita E, Lamb RA. 2007. Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles. J Virol 81:7111-7123. https://doi.org/10.1128/JVI.00361-07.
48. Chen BJ, Lamb RA. 2008. Mechanisms for enveloped virus budding: can some viruses do without an ESCRT? Virology 372:221-232. https://doi .org/10.1016/j.virol.2007.11.008.
49. Irie T, Licata JM, McGettigan JP, Schnell MJ, Harty RN. 2004. Budding of PPxY-containing rhabdoviruses is not dependent on host proteins TGS101 and VPS4A. J Virol 78:2657-2665. https://doi.org/10.1128/JVI.78 .6.2657-2665.2004.
50. Patch JR, Han Z, McCarthy SE, Yan L, Wang L-F, Harty RN, Broder CC. 2008. The YPLGVG sequence of the Nipah virus matrix protein is required for budding. Virol J 5:137. https://doi.org/10.1186/1743-422X-5-137.
51. Utley TJ, Ducharme NA, Varthakavi V, Shepherd BE, Santangelo PJ, Lindquist ME, Goldenring JR, Crowe JE. 2008. Respiratory syncytial virus uses a Vps4-independent budding mechanism controlled by Rab11-FIP2. Proc Natl Acad Sci U S A 105:10209-10214. https://doi.org/10 .1073/pnas.0712144105.
52. Park A, Yun T, Vigant F, Pernet O, Won ST, Dawes BE, Bartkowski W, Freiberg AN, Lee B. 2016. Nipah virus C protein recruits Tsg101 to promote the efficient release of virus in an ESCRT-dependent pathway. PLoS Pathog 12:e1005659. https://doi.org/10.1371/journal.ppat.1005659.
53. Honeychurch KM, Yang G, Jordan R, Hruby DE. 2007. The vaccinia virus F13L YPPL motif is required for efficient release of extracellular enveloped virus. J Virol 81:7310-7315. https://doi.org/10.1128/JVI .00034-07.
54. Shtanko O, Watanabe S, Jasenosky LD, Watanabe T, Kawaoka Y. 2011. ALIX/AIP1 is required for NP incorporation into Mopeia virus Z-induced virus-like particles. J Virol 85:3631-3641. https://doi.org/10.1128/JVI .01984-10.
55. Bieniasz PD. 2006. Late budding domains and host proteins in enveloped virus release. Virology 344:55-63. https://doi.org/10.1016/j.virol .2005.09.044.
56. Weis M, Maisner A. 2015. Nipah virus fusion protein: Importance of the cytoplasmic tail for endosomal trafficking and bioactivity. Eur J Cell Biol 94:316-322. https://doi.org/10.1016/j.ejcb.2015.05.005.
57. Rohrer J. 1996. The targeting of Lamp1 to lysosomes is dependent on the spacing of its cytoplasmic tail tyrosine sorting motif relative to the membrane. J Cell Biol 132:565-576. https://doi.org/10.1083/jcb.132.4 .565.
58. Bonifacino JS, Traub LM. 2003. Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu Rev Biochem 72:395-447. https://doi.org/10.1146/annurev.biochem.72.121801.161800.
59. Dietzel E, Kolesnikova L, Sawatsky B, Heiner A, Weis M, Kobinger GP, Becker S, von Messling V, Maisner A. 2016. Nipah virus matrix protein influences fusogenicity and is essential for particle infectivity and stability. J Virol 90:2514-2522. https://doi.org/10.1128/JVI.029 20-15.
60. DeBuysscher BL, Scott D, Marzi A, Prescott J, Feldmann H. 2014. Singledose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins. Vaccine 32: 2637-2644. https://doi.org/10.1016/j.vaccine.2014.02.087.
61. Aguilar HC, Matreyek KA, Filone CM, Hashimi ST, Levroney EL, Negrete OA, Bertolotti-Ciarlet A, Choi DY, McHardy I, Fulcher JA, Su SV, Wolf MC, Kohatsu L, Baum LG, Lee B. 2006. N-glycans on Nipah virus fusion protein protect against neutralization but reduce membrane fusion and viral entry. J Virol 80:4878-4889. https://doi.org/10.1128/JVI.80.10.4878-4889.2006.
62. Wang YE, Park A, Lake M, Pentecost M, Torres B, Yun TE, Wolf MC, Holbrook MR, Freiberg AN, Lee B. 2010. Ubiquitin-regulated nuclearcytoplasmic trafficking of the Nipah virus matrix protein is important for viral budding. PLoS Pathog 6:e1001186. https://doi.org/10.1371/journal .ppat.1001186.